• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.35 -0.22 (-1.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
32 33 Next >
Compass Pathways to Begin New Phase 2 Psychedelic Trial for Anorexia
August 09, 2022
Via Investor Brand Network
News headline image
BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets ↗
August 09, 2022
Terran Biosciences Inc. is suing COMPASS Pathways (NASDAQ: CMPS) for the appropriation of trade secrets.    
Via Benzinga
News headline image
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
August 05, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From August 4, 2022 ↗
August 04, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
News headline image
Compass Pathways Reports Q2 Financial Results, R&D Expenses Keep Growing ↗
August 04, 2022
COMPASS Pathways plc (NASDAQ: CMPS) released financial results for the second quarter 2022 and gave an update on recent progress across its business. Q2 2022 Financial Highlights 
Via Benzinga
News headline image
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today ↗
August 02, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
August 01, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
News headline image
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD ↗
July 30, 2022
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From July 29, 2022 ↗
July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
News headline image
Allied, Cybin Among Top Psychedelic Movers Of Today ↗
July 28, 2022
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
News headline image
Psilocybin For Anorexia: Learn About Compass' Novel Phase 2 Trial Using Magic Mushroom's Main Compound ↗
July 28, 2022
Psychedelics mental healthcare company Compass Pathways PLC. (NASDAQ: CMPS) has launched a phase 2 clinical study testing the efficacy of psilocybin with psychological support in people with anorexia... 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
July 27, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
July 26, 2022
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
News headline image
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
July 27, 2022
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
July 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From July 22, 2022 ↗
July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50 
Via Benzinga
News headline image
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
July 21, 2022
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45 
Via Benzinga
News headline image
Dear Psychedelic Stocks Fans, Watch This Key Catalyst ↗
July 21, 2022
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support. 
Via InvestorPlace
News headline image
Psychedelic Stock Gainers And Losers From July 20, 2022 ↗
July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11 
Via Benzinga
News headline image
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
July 19, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93 
Via Benzinga
News headline image
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know ↗
July 19, 2022
Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras. 
Via Benzinga
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
July 18, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
News headline image
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment ↗
July 18, 2022
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
July 15, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From July 14, 2022 ↗
July 14, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From July 13, 2022 ↗
July 13, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
July 12, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66 
Via Benzinga
News headline image
Psychedelic Drug Stocks Index Up Last Week, Still Down YTD ↗
July 12, 2022
The psychedelic Compounds-Based Drug Stocks Index was +24.0% last week; +33.5% in the last 5 weeks; but still -44.0% YTD. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From July 11, 2022 ↗
July 11, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54 
Via Benzinga
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
July 08, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.74% at $12.85 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap